HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerability of opioids in patients with acute pain due to nonmalignant musculoskeletal disease. A hospital-based observational study.

AbstractOBJECTIVE:
To evaluate the prevalence of adverse effects of opioids used to treat acute nonmalignant musculoskeletal pain.
METHODS:
Prospective, single-center, observational study in patients admitted to a rheumatology department for a nonmalignant painful musculoskeletal condition with onset within the last 3 months and a need for WHO Class III analgesics. The following side effects were recorded daily: nausea and vomiting, constipation, pruritus, urinary retention, drowsiness, confusion, and hallucinations.
RESULTS:
The 75 study patients (46 women and 29 men with a mean age of 56.4 years) were admitted for nerve root pain, osteoporotic vertebral fracture, inflammatory joint disease, or other disorders. First-line treatment was sustained-release morphine sulfate in a mean starting dosage of 55.2 mg/day. The dosage was increased if needed (mean maximum dosage, 78.3 mg/day). Mean treatment duration was 8.9 days. Adverse effects were recorded in 73.3% of patients but were usually minor, requiring no change in the treatment regimen. Eight patients experienced serious adverse effects (confusion in five and urinary retention in three) that resolved with no change in treatment in two patients, after dosage reduction in two patients and after substitution of fentanyl or hydromorphone hydrochloride in four patients. Treatment discontinuation was not associated with adverse effects.
CONCLUSIONS:
Morphine is often responsible for adverse effects in patients with acute nonmalignant musculoskeletal pain. These effects are usually moderate and very rarely require discontinuation of the drug.
AuthorsAnne Cherasse, Géraldine Muller, Paul Ornetti, Christine Piroth, Christian Tavernier, Jean Francis Maillefert
JournalJoint bone spine (Joint Bone Spine) Vol. 71 Issue 6 Pg. 572-6 (Nov 2004) ISSN: 1297-319X [Print] France
PMID15589442 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Analgesics, Opioid
  • Morphine
Topics
  • Acute Disease
  • Adult
  • Aged
  • Analgesics, Opioid (administration & dosage, adverse effects)
  • Female
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Morphine (administration & dosage, adverse effects)
  • Musculoskeletal Diseases (complications)
  • Pain (drug therapy, etiology)
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: